Jennifer Fitzgerald Walsh is named as a lobbyist on federal disclosure filings for 22 clients through Foley & Lardner LLP. The most recent filing naming them posted in October 2026. Issues reported include Health Issues, Medicare/Medicaid, Medical/Disease Research/Clinical Labs and Trade (domestic/foreign).
Filers must list covered executive or legislative branch positions held. As filed:
| Client | Registrant | Latest | Issues |
|---|---|---|---|
| PAR HEALTH USA, LLC | FOLEY & LARDNER LLP | Q3 2026 | Trade (domestic/foreign), Pharmacy, Health Issues |
| SAN LUIS & DELTA-MENDOTA WATER AUTHORITY | FOLEY & LARDNER LLP | Q3 2026 | Agriculture, Environment/Superfund |
| PERSONALIZED MEDICINE COALITION | FOLEY & LARDNER LLP | Q3 2026 | Health Issues |
| OMEGAFLEX | FOLEY & LARDNER LLP | Q3 2026 | Trade (domestic/foreign), Manufacturing |
| LIVANOVA USA | FOLEY & LARDNER LLP | Q3 2026 | Medicare/Medicaid, Environment/Superfund, Health Issues |
| LASH OPCO, LLC | FOLEY & LARDNER LLP | Q3 2026 | Health Issues |
| JOHNSON CONTROLS, INC. | FOLEY & LARDNER LLP | Q3 2026 | Trade (domestic/foreign), Energy/Nuclear, Manufacturing |
| HANGER INC (FORMERLY HANGER ORTHOPEDIC) | FOLEY & LARDNER LLP | Q3 2026 | Insurance, Veterans, Health Issues |
| HALOMD | FOLEY & LARDNER LLP | Q3 2026 | Medicare/Medicaid, Health Issues |
| FOUNDATION CONSUMER HEALTHCARE LLC | FOLEY & LARDNER LLP | Q3 2026 | Pharmacy, Health Issues |
| ENVISION HEALTHCARE (FORMERLY KNOWN AS EMCARE INC.) | FOLEY & LARDNER LLP | Q3 2026 | Labor Issues/Antitrust/Workplace, Budget/Appropriations, Taxation/Internal Revenue Code |
| CONSERVICE PARENT LLC | FOLEY & LARDNER LLP | Q3 2026 | Utilities |
| CALIFORNIA HOSPITAL ASSOCIATION | FOLEY & LARDNER LLP | Q3 2026 | Health Issues |
| VECTOR REMOTE CARE | FOLEY & LARDNER LLP | Q2 2026 | Medical/Disease Research/Clinical Labs |
| TEAM CYMRU, INC | FOLEY & LARDNER LLP | Q2 2026 | Telecommunications, Science/Technology |
| RHYTHM MANAGEMENT GROUP | FOLEY & LARDNER LLP | Q2 2026 | Medical/Disease Research/Clinical Labs |
| IRONROD HEALTH | FOLEY & LARDNER LLP | Q2 2026 | Health Issues |
| EQUIMED CORP | FOLEY & LARDNER LLP | Q2 2026 | Health Issues |
| CARDIAC RMS | FOLEY & LARDNER LLP | Q1 2026 | Medical/Disease Research/Clinical Labs |
| ENDO USA, INC., A MALLINCKRODT-ENDO COMPANY | FOLEY & LARDNER LLP | Q4 2025 | Pharmacy, Health Issues |
| NEXUS BRANDS GROUP, LLC | FOLEY & LARDNER LLP | Q2 2025 | Consumer Issues/Safety/Products |
| ARTHRITIS KNEE PAIN CENTERS | FOLEY & LARDNER LLP | Q2 2025 | Taxation/Internal Revenue Code, Medicare/Medicaid |
| Year | Clients | Registrants |
|---|---|---|
| 2026 | 19 | 1 |
| 2025 | 21 | 1 |
| Year | Items | Total |
|---|---|---|
| 2026 | 55 | $82K |
Pay is not disclosed for individual lobbyists. Filings do not confirm that records with the same name are one person, so this page may combine people who share the name Jennifer Fitzgerald Walsh. See the Capitol Clarity rankings and method.